White matter and neurite morphology differ in psychogenic nonepileptic seizures.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
10 2020
Historique:
received: 14 05 2020
revised: 10 08 2020
accepted: 24 08 2020
pubmed: 30 9 2020
medline: 18 8 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

To further evaluate the relationship between the clinical profiles and limbic and motor brain regions and their connecting pathways in psychogenic nonepileptic seizures (PNES). Neurite Orientation Dispersion and Density Indices (NODDI) multicompartment modeling was used to test the relationships between tissue alterations in patients with traumatic brain injury (TBI) and multiple psychiatric symptoms. The sample included participants with prior TBI (TBI; N = 37) but no PNES, and with TBI and PNES (TBI + PNES; N = 34). Participants completed 3T Siemens Prisma MRI high angular resolution imaging diffusion protocol. Statistical maps, including fractional anisotropy (FA), mean diffusivity (MD), neurite dispersion [orientation dispersion index (ODI)] and density [intracellular volume fraction (ICVF), and free water (i.e., isotropic) volume fraction (V-ISO)] signal intensity, were generated for each participant. Linear mixed-effects models identified clusters of between-group differences in indices of white matter changes. Pearson's r correlation tests assessed any relationship between signal intensity and psychiatric symptoms. Compared to TBI, TBI + PNES revealed decreases in FA, ICVF, and V-ISO and increases in MD for clusters within cingulum bundle, uncinate fasciculus, fornix/stria terminalis, and corticospinal tract pathways (cluster threshold α = 0.05). Indices of white matter changes for these clusters correlated with depressive, anxiety, PTSD, psychoticism, and somatization symptom severity (FDR threshold α = 0.05). A follow-up within-group analysis revealed that these correlations failed to reach the criteria for significance in the TBI + PNES group alone. The results expand support for the hypothesis that alterations in pathways comprising the specific PNES network correspond to patient profiles. These findings implicate myelin-specific changes as possible contributors to PNES, thus introducing novel potential treatment targets.

Identifiants

pubmed: 32991786
doi: 10.1002/acn3.51198
pmc: PMC7545605
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1973-1984

Informations de copyright

© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Soc Cogn Affect Neurosci. 2011 Oct;6(5):548-55
pubmed: 20855296
Biol Psychiatry. 2017 Nov 15;82(10):716-725
pubmed: 28359565
Front Neurosci. 2017 Dec 20;11:720
pubmed: 29326546
J Psychosom Res. 2018 Apr;107:55-61
pubmed: 29502765
Neuroimage. 2009 Sep;47(3):864-71
pubmed: 19500680
J Nerv Ment Dis. 1986 Dec;174(12):727-35
pubmed: 3783140
Neurology. 2019 Nov 5;93(19):e1787-e1798
pubmed: 31586023
J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):929-938
pubmed: 30850473
Neuropsychiatr Dis Treat. 2019 Dec 24;15:3549-3555
pubmed: 31920315
Hum Brain Mapp. 2018 Jan;39(1):428-439
pubmed: 29080235
Epilepsy Behav. 2015 Apr;45:68-73
pubmed: 25868002
Ann Clin Transl Neurol. 2017 Aug 15;4(9):663-679
pubmed: 28904988
Neuropsychopharmacology. 2019 Oct;44(11):1932-1939
pubmed: 31153156
Nat Rev Neurosci. 2009 Jun;10(6):397-409
pubmed: 19469025
Neuroimage Clin. 2016 Apr 12;11:539-547
pubmed: 27158586
Epilepsia. 2005 Sep;46(9):1465-71
pubmed: 16146442
Sci Adv. 2020 Aug 07;6(32):eaaz6892
pubmed: 32821816
Epilepsy Behav. 2013 Feb;26(2):153-7
pubmed: 23314302
J Psychiatr Res. 2014 Jul;54:126-33
pubmed: 24703187
Seizure. 2018 May;58:127-132
pubmed: 29702410
Neuropsychiatry Neuropsychol Behav Neurol. 2001 Jul-Sep;14(3):169-76
pubmed: 11513100
Epilepsia. 2013 Nov;54(11):2005-18
pubmed: 24111933
Radiology. 2004 Jan;230(1):77-87
pubmed: 14645885
Epilepsia. 2013 Apr;54(4):718-25
pubmed: 23281644
J Neurosci. 2012 Nov 28;32(48):17365-72
pubmed: 23197727
Annu Rev Clin Psychol. 2012;8:49-76
pubmed: 22224834
Neuropsychiatr Dis Treat. 2015 Jan 08;11:97-106
pubmed: 25657582
Neurol Clin. 2011 Feb;29(1):35-47, vii
pubmed: 21172569
Psychosomatics. 2019 Jul - Aug;60(4):365-375
pubmed: 30342702
J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):239-47
pubmed: 22056967
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):491-497
pubmed: 28416565
Clin Neurol Neurosurg. 2009 Jan;111(1):1-9
pubmed: 19019531
Arch Gen Psychiatry. 1976 Jun;33(6):766-71
pubmed: 938196
PLoS One. 2013 May 22;8(5):e63850
pubmed: 23717498
Exp Neurol. 2016 Jan;275 Pt 3:328-333
pubmed: 25697845
Hum Brain Mapp. 2015 Sep;36(9):3687-702
pubmed: 26096639
Psychoneuroendocrinology. 2010 Jan;35(1):179-91
pubmed: 19362426
J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1052-1059
pubmed: 28844071
Neuroimage. 2012 Jul 16;61(4):1000-16
pubmed: 22484410
Epilepsy Curr. 2018 Jul-Aug;18(4):211-216
pubmed: 30254510
J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1221-1224
pubmed: 29326291
Top Magn Reson Imaging. 2008 Apr;19(2):97-109
pubmed: 19363432
Epilepsy Behav. 2009 Nov;16(3):491-4
pubmed: 19786368
JAMA Psychiatry. 2014 Sep;71(9):997-1005
pubmed: 24989152
J Magn Reson Imaging. 2006 Jun;23(6):827-39
pubmed: 16649196
Epilepsy Res. 2003 Dec;57(2-3):159-67
pubmed: 15013057
Neuroimage Clin. 2019;24:101967
pubmed: 31446314
Brain Res. 2015 Sep 16;1620:169-76
pubmed: 25979311
Epilepsia. 2012 Feb;53(2):377-85
pubmed: 22150750
Neuroimage. 2008 Jan 1;39(1):336-47
pubmed: 17931890
Psychol Med. 2021 Feb;51(3):485-493
pubmed: 31769368
Mol Psychiatry. 2020 Dec;25(12):3350-3359
pubmed: 30120414

Auteurs

Adam M Goodman (AM)

Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Jane B Allendorfer (JB)

Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Andrew S Blum (AS)

Department of Neurology, Rhode Island Hospital, Providence, Rhode Island, USA.
Brown University, Providence, Rhode Island, USA.

Mark S Bolding (MS)

Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Stephen Correia (S)

Brown University, Providence, Rhode Island, USA.
Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Rhode Island Hospital, Providence, Rhode Island, USA.
Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA.

Lawrence W Ver Hoef (LW)

Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Birmingham VA Medical Center, Birmingham, Alabama, USA.

Tyler E Gaston (TE)

Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Birmingham VA Medical Center, Birmingham, Alabama, USA.

Leslie E Grayson (LE)

Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Birmingham VA Medical Center, Birmingham, Alabama, USA.
Children's of Alabama, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Nina V Kraguljac (NV)

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Adrienne C Lahti (AC)

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Departments of Neurobiology and Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Amber N Martin (AN)

Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.

William S Monroe (WS)

Department of Research Computing, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Noah S Philip (NS)

Brown University, Providence, Rhode Island, USA.
Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA.

Krista Tocco (K)

Department of Neurology, Rhode Island Hospital, Providence, Rhode Island, USA.
Brown University, Providence, Rhode Island, USA.
Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA.

Valerie Vogel (V)

Department of Neurology, Rhode Island Hospital, Providence, Rhode Island, USA.
Brown University, Providence, Rhode Island, USA.
Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA.

W Curt LaFrance (WC)

Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, Rhode Island, USA.
Departments of Psychiatry and Neurology, Rhode Island Hospital and Brown University, Providence, Rhode Island, USA.

Jerzy P Szaflarski (JP)

Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Children's of Alabama, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Departments of Neurobiology and Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Comprehensive Neuroscience Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH